Categories AlphaGraphs, Earnings, Health Care
Key highlights from Abbott Laboratories (ABT) Q1 2024 earnings results
Abbott Laboratories (NYSE: ABT) reported its first quarter 2024 earnings results today.
Total sales increased 2.2% year-over-year to $10 billion. Organic sales growth was 10.8%.
Net earnings decreased 7% to $1.22 billion, or $0.70 per share, compared to last year. Adjusted EPS decreased 5% to $0.98.
Abbott expects GAAP EPS of $3.25-3.40 and adjusted EPS of $4.55-4.70 for full-year 2024. The company projects GAAP EPS of $0.69-0.73 and adjusted EPS of $1.08-1.12 for the second quarter of 2024.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Best Buy set for modest Q3 gains amid cautious outlook
Best Buy Co., Inc. (NYSE: BBY) is navigating a challenging retail backdrop, marked by cautious consumer spending and tariff-related cost pressure. The consumer electronics retailer's upcoming earnings report is expected
J.M. Smucker (SJM) anticipated to report mixed results for Q2 2026
Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Monday. The stock has dropped 3% in the past three months. The branded foods company is scheduled to report
Intuit (INTU) set to report Q1 FY26 results. Here’s what to expect
Intuit Inc. (NASDAQ: INTU) is preparing to report results for the first three months of fiscal 2026, amid expectations for a double-digit increase in revenues and adjusted earnings. While the
